Clinical Trials Browser

Phase 1/2 × LY6K protein, human × Thoracic × Clear all

NCT00674258 2008-05-14

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung